EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delaney, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Delaney, B.
Evidence-Based Medicine 2003; 8:20
© 2003 BMJ Publishing Group


Therapeutics

Noninvasive Helicobacter pylori testing was as effective as endoscopy for managing dyspepsia

McColl KE, Murray LS, Gillen D, et al.Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia.BMJ 2002 ;324:999–1002[Abstract/Free Full Text]

QUESTION: In patients with upper gastrointestinal symptoms presenting for investigation of dyspepsia, is treatment based on a urea breath test for Helicobacter pylori alone as effective as endoscopy and urea breath testing?

Key Words: dyspepsia • Helicobacter pylori • breath tests • gastroscopy

The first 150 words of the full text of this article appear below.

Design
Randomised {allocation concealed*}{dagger}, unblinded,* controlled trial with 1 year of follow up.

Setting
A gastroenterology clinic in Glasgow, UK.

Patients
708 patients (mean age 37 y, 53% men) who were referred by their general practitioners for investigation of upper gastrointestinal symptoms. Exclusion criteria were age >55 years, nonsteroidal anti-inflammatory drugs, or sinister symptoms. Follow up was 83%.

Intervention
Patients were allocated to endoscopy plus the noninvasive 14C-urea breath test (n=352) or the breath test alone (n=356) for determination of H pylori status. Patients were informed of their status after the test, and patients with positive results were prescribed a 7 day course of H pylori eradication treatment with omeprazole, 20 mg twice daily; clarithromycin, 250 mg 3 times daily; and amoxicillin, 500 mg (or metronidazole, 400 mg) 3 times daily.

Main outcome measures
Change from baseline on the Glasgow Dyspepsia Severity Score (GDSS). Secondary outcomes were use of medical resources, patient assessment of the . . . [Full text of this article]

Brendan Delaney, MD, FRCP, MRCGP

University of Birmingham
Birmingham, UK







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.